Enhance fair access to covid 19 vaccines through the waiver of intellectual property rights – recommendations for vietnam

HO CHI MINH CITY UNIVERSITY OF LAW FACULTY OF INTERNATIONAL LAW -*** LE THANH THAO Student ID: 1751101030139 ENHANCE FAIR ACCESS TO COVID-19 VACCINES THROUGH THE WAIVER OF INTELLECTUAL PROPERTY RIGHTS – RECOMMENDATIONS FOR VIETNAM BACHELOR’S THESIS School Year: 2017 - 2022 Supervisor: LL.M Ngo Kim Hoang Nguyen Ho Chi Minh City – Year 2022 HO CHI MINH CITY UNIVERSITY OF LAW FACULTY OF INTERNATIONAL LAW -*** LE THANH THAO Student ID: 1751101030139 ENHANCE FAIR ACCESS TO COVID-19 VACCINES THROUGH THE WAIVER OF INTELLECTUAL PROPERTY RIGHTS – RECOMMENDATIONS FOR VIETNAM BACHELOR’S THESIS School Year: 2017 - 2022 Supervisor: LL.M Ngo Kim Hoang Nguyen Ho Chi Minh City – Year 2022 DECLARATION I, hereinafter, declare that the bachelor thesis of “Enhance fair access to COVID-19 vaccines through the waiver of Intellectual Property rights - Recommendations for Vietnam”, which has been carried out under the supervision of LL.M Ngo Kim Hoang Nguyen, represents my own research work unless otherwise cited or acknowledged by means of complete references Therefore, I take full responsibility for this declaration Ho Chi Minh City, June 29, 2022 Le Thanh Thao TABLE OF CONTENTS INTRODUCTION 01 CHAPTER I: ACCESS TO COVID-19 VACCINES AS THE FOUNDATION OF HUMAN RIGHT 09 1.1 Overview of Human rights 09 1.1.1 Concept of Human rights 09 1.1.2 Approached tendencies of Human rights 11 1.1.3 Characteristics and features of Human rights 12 1.2 Access to COVID-19 vaccines as a human right 13 1.2.1 Right to health 13 1.2.2 Right to enjoy the benefits of scientific progress and its applications 22 1.2.3 Conclusion 24 1.3 International practice regarding access to COVID-19 vaccines 26 1.3.1 Introduction to COVID-19 Vaccines Global Access 26 1.3.2 International vaccination and distribution of COVID-19 vaccines 28 SUBCONCLUSION OF CHAPTER I 31 CHAPTER II: WAIVER OF INTELLECTUAL PROPERTY RIGHTS ON COVID-19 VACCINES – RECOMMENDATIONS FOR VIETNAM 33 2.1 The interface between Intellectual Property rights and Human rights 36 2.1.1 Approaches to the interface between Intellectual Property rights and Human rights 36 2.1.2 Intellectual Property rights, right to health and right to enjoy the benefits of scientific progress and its applications 37 2.2 Waiver of Intellectual Property rights on COVID-19 vaccines 39 2.2.1 Legal framework for waiving Intellectual Property rights for COVID-19 vaccines 40 2.2.2 The insufficiency of compulsory licensing and voluntary licensing 49 2.2.3 Global reaction regarding the waiver of Intellectual Property rights on COVID-19 vaccines 56 2.3 Recommendations for Vietnam 62 2.3.1 Utilizing the Decision on TRIPS Agreement to issue compulsory licenses 62 2.3.2 Other recommendations 64 SUBCONCLUSION OF CHAPTER II 68 CONCLUSION OF THESIS 70 BIBLIOGRAPHY 72 LIST OF ABBREVIATIONS ACT-A CEPI CESCR Access to COVID-19 Tools Accelerator Coalition for Epidemic Preparedness Innovations Committee on Economic, Social and Cultural Rights COVAX COVID-19 Council for TRIPS COVID-19 Vaccines Global Access Coronavirus disease Council for Trade-Related Aspects of Intellectual Property Rights DOHA Declaration Declaration on the TRIPS agreement and public health C-TAP GAVI HRs ICESCR COVID-19 Technology Access Pool Global Alliance for Vaccines and Immunization Human rights International Covenant on Economic, Social and Cultural Rights IP Intellectual Property LDCs Least-developed countries LOIP Law on Intellectual Property Marrakesh Agreement Marrakesh Agreement Establishing the World Trade Organization NGOs OHCHR Non-governmental organizations Office of the United Nations High Commissioner for Human Rights TRIPS Agreement Agreement on Trade-Related Aspects of Intellectual Property Rights WHO World Health Organization WTO UDHR World Trade Organization Universal Declaration of Human Rights INTRODUCTION Imperativeness of the study With deep concern both of the alarming levels of spread and severity and of the alarming levels of inaction, on March 11, 2020, the World Health Organization has declared the coronavirus disease (“COVID-19”) caused by the SARS-CoV-2 virus outbreak a global pandemic Since then the world has been in a race to develop vaccines that can control the COVID-19 pandemic In 2021, more than 250 projects have been initiated for this purpose, but only 14 of them have been authorized for use, despite being in phase clinical trials More than 40 other vaccines are also in phase 1/2 clinical trials and show promising outcomes However, as WHO especially emphazies “it’s not vaccines that will stop the pandemic, it’s vaccination”3 On the other hand, the current situation of COVID-19 vaccination in the world has shown that COVID-19 vaccines have not been distributed and accessed equitably leading to the failure of States to comply with their obligation to ensure access to COVID-19 vaccines for everyone, everywhere since such access is realized to be a Human right One of the main reasons leading to the above problem is the protection of Intellectual Property (“IP”) rights for COVID-19 vaccines Even though, IP protection has a strong and positive impact on socio-economic development, it also has certain negative effects, especially in the current context of COVID-19 pandemic IP rights WHO, “WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020”, March 11, 2020, https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarksat-the-media-briefing-on-covid-19 -11-march-2020 (Accessed on June 10, 2022) Zainalabideen A Abdulla et al., “A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development”, Pathogens, No 10(7):788, 2021, page WHO, “COVID-19 vaccines”, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19- vaccines (Accessed on June 10, 2022) protection is characterized by general IP law, which is territorial However, the Covid19 pandemic did not stop within the territory of any one country, but created a global crisis.4 It has become a big deal for countries when they have to fulfill strict obligations imposed by the TRIPS agreement Therefore, the first pioneers such as India and South Africa and then fellow countries have proposed a waiver of IP rights toward COVID19 health products and technologies, including vaccines Such waiver presents an important opportunity for all States to unite and protect public health, global solidarity, and fair access through a concrete step at the international level that can provide an automatic and expedited solution to collectively address IP and technology challenges In this context, the TRIPS waiver is a critical legal instrument for enabling a significant increase in COVID-19 vaccine manufacturing capacity and thus supply, paving the way for global equitable production and access In terms of the balance between economic and social benefits, there is no absolute balance between economic benefits or social benefits, and to resolve the conflict between Human rights (“HRs”) and IP rights, it requires a long time of research with the adjustment of a synchronous and appropriate IP legal system It should be emphasized that waiver of IP rights for Covid19 vaccines is necessary because IP holders have many opportunities to reap economic Nguyen Van Quan, Vu Thanh Cu, “The right to access vaccines to prevent Covid-19 in the current context”, Journal of Legislative Studies, Vol 02+03 (450+451), 2022, http://lapphap.vn/Pages/TinTuc/211029/Quyen-tiepcan-vac-xin-phong-ngua-Covid-19-trong-boi-canh-hien-nay.html, (Accessed on June 13, 2022) Médecins Sans Frontières, India and South Africa proposal for WTO waiver from intellectual property protections for COVID-19-related medical technologies, Briefing Document, 2020, page Siva Thambisetty et al., The TRIPS Intellectual Property Waiver Proposal: Creating the Right Incentitives in Patent Law and Politics to end the COVID-19 Pandemic, Society and Economy Working Papers, LSE Legal Studies Working Paper No.06/2021, 2021, page profits while less than one year, the COVID-19 pandemic have claimed the lives of millions of people due to the barriers from the IP system itself Furthermore, with the vaccination policy for children 5-12 years old8 and the plan for vaccinating the nd booster shot (4th and other future dose) for those who need to be vaccinated, including the elderly (60 years old and older), people with background diseases, workers in industrial zones or crowded areas 9, Vietnam, at the present, still has a high demand for COVID-19 vaccines In other words, Vietnam still need to enhance the access of our children to COVID-19 vaccination and our poupulation in general to the 4th and other future dose vaccination and the waiver of IP rights shall act as a necessary legal instrument that will assist Vietnam in this regard With the desire to study in detail, specifically and thoroughly about the access vaccines from the perspective of HRs and the waiver of IP rights toward CVOID-19 vaccines, the author decided to choose the topic “Enhance fair access to COVID-19 vaccines through the waiver of Intellectual Property rights – Recommendations for Vietnam” as the topic of Bachelor of Law thesis Literature review Generally, access to medicines is not a new topic However, when placed in the context of the COVID-19 pandemic affecting the health of all mankind and causing the death of millions of people, the issue of access to medicines, specifically in this thesis, is the access to COVID-19 vaccines is of greater concern than ever While global Nguyen Van Phuc, “Waiver of Intellectual Property rights for COVID-19 vaccines to access the community's entitlement to health care”, Journal of Legislative Studies, Vol 08 (456), 2022 http://www.lapphap.vn/Pages/tintuc/tinchitiet.aspx?tintucid=211080 (Accessed on June 29, 2022) Resolution No 55/NQ-CP dated April 14, 2022 of the Government Office of Socialist Republic of Vietnam on COVID-19 vaccination for children from to 12 years old Notification No 114/TB-VPCP dated April 15, 2022 of the Government Office of Socialist Republic of Vietnam on the Conclusion of Prime Minister Pham Minh Chinh at the 14th online meeting of the National Steering Committee for COVID-19 prevention and control with localities, paragraph 5, page 74 Bolivia, Egypt, Eswatini, Fiji, India, Indonesia, Kenya, the LDC Group, Maldives, Mozambique, Mongolia, Namibia, Pakistan, South Africa, Vanuatu, the Bolivarian Republic of Venezuela and Zimbabwe”, IP/C/W/669/Rev.1, 2021 24 WTO, “Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19, Communication from the African Group, the Plurinational State of Bolivia, Egypt, Eswatini, Fiji, India, Indonesia, Jordan, Kenya, the LDC Group, Malaysia, Maldives, Mozambique, Mongolia, Namibia, Pakistan, South Africa, Vanuatu, the Bolivarian Republic of Venezuela and Zimbabwe”, IP/C/W/684, 2021 25 II Vienna Declaration and Programme of Action1993 MATERIALS Vietnamese Materials Do Bui Dieu Huyen, Conditions on compulsory licensing of patents for COVID-19 vaccines - An approach from a legal and practical perspective of Viet Nam, Bachelor’s Thesis, Ho Chi Minh City University of Law, 2021 Ho Chi Minh City University of Law, Monograph Book of Human Rights in International and Vietnamese law, Hong Duc Publishing House Vietnam Bar Association, Ho Chi Minh City, 2014 Nguyen Ho Bich Hang, “COVID-19 and Challenges to Intellectual Property Rights”, Vietnamese Journal of Legal Science, Vol 04 (143), 2021, page 27-41 Nguyen Van Phuc, “Waiver of Intellectual Property rights for COVID-19 vaccines to access the community's entitlement to health care”, Journal of Legislative Studies, Vol 08 (456), 2022 75 Nguyen Van Quan, Vu Thanh Cu, “The right to access vaccines to prevent Covid-19 in the current context”, Journal of Legislative Studies, Vol 02+03 (450+451), 2022 Tran Kien et al., The conflict between human rights and intellectual property rights - Approach from legal philosophy and legal practice, Vietnam National University Hanoi Publishing House, Vietnam National University Hanoi – Law Department, 2020, Hanoi, Vu Cong Giao et al., Question and Answer on Human Rights, Rights and Obligations of Citizens (Revised and Supplemented Edition), National Political Publishing House, Hanoi, 2016 English Materials Asbjorn Eide et al., Economic, Social and Cultural Rights – A Textbook, Martinus Nijhoff Publishers, Netherlands, 1995 Audrey R Chapman, “A Human Rights Perspective on Intellectual Property, Progress, and Access to the Benefits of Science”, Intellectual Property and Human Rights – A Panel Discussion to commemorate the 50th Anniversary of the Universal Declaration of Human Rights, 1998 Biswajit Dhar, K.M Gopakumar, India – South Africa proposal for a waiver from certain obligations under the TRIPS Agreement, Third World Network, Briefing Paper, 2020 Darren J O’Byrne, Human Rights – An introduction, Routledge, 2013 De Menezes, Henrique Zeferino, The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines, Research Paper No 129, South Centre, Geneva, 2021 Hans V Hogerzeil et al., “Is access to essential medicines as part of the fulfillment of the right to health enforceable through the courts?”, The Lancet, Vol 368, 2006 76 Heath Kelly, “The classical definition of a pandemic is not elusive”, Bulleting of the World Health Organization, Vol 89 No 7, 2011, page 540 Holger Hestermeyer, “Access to Medicine as a Human Right”, Human Rights and the WTO – The Casse of Patents and Access to Medicine, Oxford, 2007 International AIDS Society and Desmond M Tutu Endowment in Public Health and Human Rights at the Johns Hopkins University, “Human rights and fair access to COVID-19 vaccines: the International AIDS Society–Lancet Commission on Health and Human Rights”, The Lancet, Vol 397, 2021 10 Jack Donnely, “Human Rights as Natural Rights”, Human Rights Quarterly, Vol No.3, 1982 11 Jonathan M Mann et al., “Health and Human Rights”, Health and Human Rights, Vol No.1, 1994 12 Karen Hussman, Global access to COVID-19 vaccines: Lifting the veil of opacity, U4 Issue 2021:12, U4 Anti-Corruption Resource Centre, 2021 13 Laurence R Helfer, “Human Rights and Intellectual Property: Conflict or Coexistence”, Minnesota Intellectual Property Review, Vol No 1, 2003 14 Lisa M Herzog et al., “Covax must go beyond proportional allocation of COVID vaccines to ensure fair and equitable access”, BMJ Clinical Research 2021:372m4853, 2021 15 Matthew Rimmer, “The People’s Vaccines: Intellectual Property, Access to Essential Medicines, and COVID-19”, Journal of Intellectual Property Studies, Vol Issue 1, 2022 77 16 Maxwell J Smith et al., “Should COVID-19 Vaccines Authorized for Emergency Use Be Considered Essential” Medicines?”, Health and Human Rights Journal, Vol 23 No 1, 2021 17 Médecins Sans Frontières, Compulsory Licenses, the TRIPS Waiver and Access to COVID-19 Medical Technologies, MSF Briefing Document, 2021 18 Médecins Sans Frontières, India and South Africa proposal for WTO waiver from intellectual property protections for COVID-19-related medical technologies, Briefing Document, 2020 19 Médecins Sans Frontières, Overcoming intellectual property monopolies in the COVID-19 pandemic, MSF Briefing Document, 2020 20 Michael Freeman, Human Rights, Key Concepts Series, Fourth Edition (Fully Revised and Updated), 2022 21 OHCHR, Frequently Asked Question On A Human Rights-based Approach To Development Cooperation, 2006 22 OHCHR, United Nations Staff College Project, Human Rights – A Basic Handbook for UN Staff 23 Peter K Yu, “Intellectual Property and Human Rights in the Nonmultilateral Era”, Florida Law Review, Vol 64 No 4, 2012 24 Philip Loft, Waiving intellectual property rights for Covid-19 vaccines, Research Briefing No 9417, House of Commons Library, 2022 25 Prabhash Ranjan, The Case for Waiving Intellectual Property Protection for COVID-19 Vaccines, Issue Brief, Issue No 456, Observer Research Foundation, 2021 26 Rojina Thapa, “Waiver Solution in Public Health and Pharmaceutical Domain under TRIPS Agreement”, Journal of Intellectual Property Rights, Vol 16, 2011 78 27 Ronald Labonté et al., “Canada, global vaccine supply, and the TRIPS waiver”, Canadian Journal of Public Health, Vol 112, 2021 28 Siva Thambisetty et al., The TRIPS Intellectual Property Waiver Proposal: Creating the Right Incentives in Patent Law and Politics to end the COVID-19 Pandemic, Society and Economy Working Papers, LSE Legal Studies Working Paper No 06/2021, 2021 29 Talha Khan Burki, “Ensuring fair distribution of COVID-19 vaccines: is an intellectual waiver the answer?”, Lancet Respir Med 2021, 2021 30 United Nations Secretary-General’s High-Level Panel on Access to Medicines, “Report of the Secretary-General’s High-Level Panel on Access to Medicines – Promoting innovation and access to health technologies”, 2016 31 WHO, 25 Questions and Answers on Health and Human Rights, Health and Human rights Publication Series Issue No 1, 2002 32 Yang Ye et al., “Equitable access to COVID-19 vaccines makes a lifesaving difference to all countries”, Nature Human Behaviour, Vol 6, 2022 33 Zainalabideen A Abdulla et al., “A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development”, Pathogens, No 10(7):788, 2021 III WEBSITES American Association For The Advancement Of Science, “Right to Science: FAQs”, https://www.aaas.org/programs/scientific- responsibility-human-rightslaw/resources/faqs#:~:text=The%20right%20to%20the%20benefits%20o f%20scientific%20progress%20was%20first,(ICESCR)%20(1966) (Accessed on May 22, 2022) 79 Aljazeera, “Developing nations demand equal access to coronavirus vaccines”, March 10, 2021, https://www.aljazeera.com/news/2021/3/10/countries-continue-push-forequal-access-to-coronavirus-vaccines (Accessed on June 06, 2022) Ashleigh Furlong, “Compromise reached on COVID-19 vaccine intellectual property rights waiver”, Politico, March 15, 2022, https://www.politico.eu/article/compromise-reached-on-COVID-19vaccine-intellectual-property-rights-waiver/ (Accessed on June 06, 2022) Bretton Woods Project, “Malpass makes World Bank a pariah with opposition to TRIPS waiver”, July 13, 2021, https://www.brettonwoodsproject.org/2021/07/malpass-makes-worldbank-a-pariah-with-opposition-to-trips-waiver/ (Accessed on June 13, 2022) Chambre de Commerce et d’Industrie France-Vietnam, “COVID-19 vaccination in Vietnam”, February 14, 2022, https://www.ccifv.org/en/vietnam/covid-19-information/covid-19vaccination-in-vietnam.html (Accessed on June 29, 2022) Claire Felter, “A Guide to Global COVID-19 Vaccine Efforts”, Council on Foreign Relations, April 01, 2022, https://www.cfr.org/backgrounder/guide-global-COVID-19-vaccineefforts (Accessed on May 22, 2022) European Union, “EU Statements at the General Council Meeting, 22-23 November 2021”, November 23, https://www.eeas.europa.eu/delegations/world-trade-organizationwto/eu-statements-general-council-meeting-22-23-november2021_en?s=69 (Accessed on June 06, 2022) 2021, 80 James Love, “The June 17, 2022 WTO Ministerial Decision on the TRIPS Agreement”, Knowledge Ecology International, June 17, 2022, https://www.keionline.org/37830 (Accessed on June 18, 2022) Hai Lien, “Amending and supplementing a number of articles of the Law on Intellectual Property”, Government News of Socialist Republic of Vietnam, June 16, 2022, https://baochinhphu.vn/sua-doi-bo-sung-mot-sodieu-cua-luat-so-huu-tri-tue10222061609391233.htm?fbclid=IwAR0lsYyQLZcOm25qMcRIV9NW 4SYx1QsSl1w9_lxQJXSYIbasO_Gaj2lJnbQ (Accessed on June 29, 2022) 10 Hai Minh, “Minister Huynh Thanh Dat calls for waiver of Intellectual Property rights of COVID-19 vaccines”, VNExpress, October 03, 2021, https://vnexpress.net/bo-truong-huynh-thanh-dat-keu-goi-tu-bo-quyenso-huu-tri-tue-voi-vaccine-covid-19-4366630.html (Accessed on June 28, 2022) 11 Hannah Ritchie et al., “Coronavirus Pandemic (COVID-19)”, https://ourworldindata.org/covid-vaccinations (Accessed on May 22, 2022) 12 Health Action International, “Health Action International statement following the conclusion of the WTO 12th Ministerial Conference”, June 17, 2022, https://haiweb.org/wp- content/uploads/2022/06/HAI_Statement_MC12agreement_final-1.pdf (Accessed on June 18, 2022) 13 Joe C Mathew, “No consensus on India-South Africa’s WTO proposal to waive off patent rights for COVID-19 innovation”, BusinessToday.In, October 18, 2020, https://www.businesstoday.in/latest/economy- politics/story/no-consensus-on-india-south-africas-wto-proposal-to- 81 waive-off-patent-rights-for-COVID-19-innovation-276104-2020-10-18, (Accessed on June 06, 2022) 14 Medicines Law & Policy, “WTO Covid-19 TRIPS Decision: Some observations”, June 17, 2022, https://medicineslawandpolicy.org/2022/06/wto-covid-19-trips-decisionsome-observations/ (Accessed on June 18, 2022) 15 Médecins Sans Frontières, “Inability to agree a real pandemic intellectual property Waiver at WTO is a devastating global failure for people the world over”, June 17, 2022, https://msf-access- campaign.prezly.com/inability-to-agree-a-real-pandemic-intellectualproperty-waiver-at-wto-is-a-devastating-global-failure-for-people-theworld-over (Accessed on June 18, 2022) 16 Médecins Sans Frontières, “WTO COVID-19 TRIPS waiver proposal: Myths, realities and an opportunity for governments to protect access to lifesaving medical tools in a pandemic”, December 03, 2020 https://msfaccess.org/wto-covid-19-trips-waiver-proposal-mythsrealities-and-opportunity-governments-protect-access (Accessed on June 06, 2022) 17 Megha Kaveri, “WTO ministerial: civil society groups urge ministers to reject TRIPS waiver text”, Geneva Solutions, June 15, 2022, https://genevasolutions.news/global-health/wto-ministerial-civil-societygroups-urge-ministers-to-reject-trips-waiver-text (Accessed on June 16, 2022) 18 Ministry of Health, “Vietnam is one of 11 countries that WHO has transferred technology for producing mRNA vaccines”, February 24, 2022,https://moh.gov.vn/tin-noi-bat//asset_publisher/3Yst7YhbkA5j/content/viet-nam-la-1-trong-11-quoc- 82 gia-uoc-who-chuyen-giao-cong-nghe-san-xuat-vaccine-mrna (Accessed on June 26, 2022) 19 National Cancer Institute, Dictionaries, NCI “Medication”, https://www.cancer.gov/publications/dictionaries/cancerterms/def/medication (Accessed on May 22, 2022) 20 OHCHR, “What are human rights?”, https://www.ohchr.org/en/what-arehuman-rights (Accessed on May 22, 2022) 21 OHCHR, “Statement by UN Human Rights Experts Universal access to vaccines is essential for prevention and containment of COVID-19 around the world”, November 09, 2020, https://www.ohchr.org/en/statements/2020/11/statement-un-humanrights-experts-universal-access-vaccines-essential-prevention (Accessed on May 21, 2022); 22 Oxford Vaccine Group, “What is a vaccine, and how vaccines work?”, January 03, 2019, https://vk.ovg.ox.ac.uk/vk/how-do-vaccineswork (Accessed on May 22, 2022) 23 Pan American Health Organization, WHO, “The Links between Health and Human Rights”, https://www3.paho.org/hq/index.php?option=com_content&view=article &id=1348:links-between-heath-human-rights&Itemid=643&lang=en (Accessed on May 22, 2022) 24 Permanent Mission of India, “India’s Statement delivered by Ambassador & PR to the WTO at the General Council Meeting held on 18 December, 2020 on Agenda Item No 13B - Status Report on the Consideration by the TRIPS Council of the ‘Proposal for Waiver from Certain Provisions of the TRIPS Agreement for the Prevention, Containment and Treatment of COVID-19’ – Statement by the Chair of 83 the Council for TRIPS”, https://pmindiaun.gov.in/statements/MjM2Mg (Accessed on June 06, 2022) 25 Pharmaceutical Technology, “Over 120 countries back IP rights waiver on Covid-19 vaccines”, May 07, 2021, https://www.pharmaceuticaltechnology.com/news/ip-waiver-COVID-19-vaccines/ (Accessed on June 06, 2022) 26 Prashant Yadav, Rebecca Weintraub, “4 Strategies to Boost the Global Supply of Covid-19 Vaccines”, Harvard Business Review, May 06, 2021, https://hbr.org/2021/05/4-strategies-to-boost-the-global-supply-of-covid19-vaccines (Accessed on June 29, 2022) 27 Priti Patnaik, “No consensus on TRIPS talks; WHO Foundation”, Geneva Health Files, December 11, 2020 https://genevahealthfiles.substack.com/p/no-consensus-on-trips-talkswho-foundation?s=r (Accessed on June 06, 2022) 28 Public Citizen, “Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and COVID at 12th WTO Ministerial”, June 16, 2022, https://www.citizen.org/news/undemocratic-wto-processes- produce-shameful-result-on-covid-trips-waiver-at-12th-ministerial/ (Accessed on June 19, 2022) 29 Reuters, “U.S urges all WTO members to support intellectual property waiver for COVID-19 vaccines”, October 22, 2021, https://www.reuters.com/world/us/white-house-wto-members-mustsupport-intellectual-property-waiver-covid-vaccines-2021-10-21/ (Accessed on June 06, 2022) 30 Thao Mien, “Vietnam contributes one million USD to COVAX Program”, Vietnam Financial Times, November 04, 2021, 84 https://thoibaotaichinhvietnam.vn/viet-nam-dong-gop-cho-chuong-trinhcovax-1-trieu-usd-94796.html (Accessed on June 29, 2022) 31 The People’s Vaccine, “Frequently Asked Question”, March 10, 2022, https://peoplesvaccine.org/faq/ (Accessed on May 22, 2022) 32 The White House, “Statement by President Joe Biden on the Omicron Variant”, COVID-⁠19 November 26, 2021, https://www.whitehouse.gov/briefing-room/statementsreleases/2021/11/26/statement-by-president-joe-biden-on-the-omicronCOVID-19-variant/ (Accessed on June 06, 2022) 33 Third World Network, ““Global approach” based on TRIPS waiver needed to combat Covid-19”, January 29, 2021, https://www.twn.my/title2/intellectual_property/info.service/2021/ip2101 10.htm (Accessed on June 06, 2022) 34 Trade Justice Education Fund, “Actions Governments Can Take Now to Help Save Lives and End the Pandemic”, June 17, 2022, https://tradejusticeedfund.org/actions-governments-can-take-now-tohelp-save-lives-and-end-the-pandemic/?fbclid=IwAR0cTVY1HnMtL4Xz3hn4i6D-huEeke1EOvkrfC4MibOEY_GOISeE9f1G2c (Accessed on June 28, 2022) 35 United Kingdom Government, “World Trade Organization General Council, November 2021: UK statements”, November 24, 2021, https://www.gov.uk/government/speeches/world-trade-organizationgeneral-council-november-2021-ukstatements?utm_source=HOC+Library++Current+awareness+bulletins&utm_campaign=d40063d6acCurrent_Awareness_IADS_25_11_2021&utm_medium=email&utm_ter m=0_f325cdbfdc-d40063d6ac- 85 103780026&mc_cid=d40063d6ac&mc_eid=ec2ad28b66 (Accessed on June 06, 2022) 36 United Nations Development Programme, “Global Dashboard for Equity”, Vaccine https://data.undp.org/vaccine- equity/?utm_source=EN&utm_medium=GSR&utm_content=US_UNDP _PaidSearch_Brand_English&utm_campaign=CENTRAL&c_src=CENT RAL&c_src2=GSR&gclid=Cj0KCQjwm6KUBhC3ARIsACIwxBiPN19i Yt0tLqELy1GobCAgZfhlMiHElfRL4w4DJ6tiVCSrIQYFVNAaAjNcEA Lw_wcB (Accessed on May 22, 2022) 37 United Nations Office for the Coordination of Humanitarian Affairs, “Oxfam reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool”, ReliefWeb, November 17, 2021, https://reliefweb.int/report/world/oxfam-reaction-pfizer-s-announcementvoluntary-licenses-its-COVID-19-oral-antiviral (Accessed on June 03, 2022) 38 WHO, “COVAX Allocation”, https://www.who.int/initiatives/act- accelerator/covax/allocation (Accessed on May 22, 2022) 39 WHO, “COVID-19 vaccines”, https://www.who.int/emergencies/diseases/novel-coronavirus2019/covid-19-vaccines (Accessed on June 10, 2022) 40 WHO, “COVID-19 vaccines WHO EUL issued”, https://extranet.who.int/pqweb/vaccines/vaccinesCOVID-19-vaccine-eulissued (Accessed on May 22, 2022) 41 WHO, “Use of Emergency Use Listing procedure for vaccines against COVID-19 – Q&A”, July 16, 2020, 86 https://extranet.who.int/pqweb/sites/default/files/documents/QA_EUL_C OVID-19_July2020.pdf (Accessed on May 22, 2022) 42 WHO, “The ACT-Accelerator frequently asked questions”, https://www.who.int/initiatives/act-accelerator/faq (Accessed on May 22, 2022) 43 WHO, “Vaccine Equity”, https://www.who.int/campaigns/vaccine- equity?fbclid=IwAR37IC6ynJFKGRRXkaFzov903guKWtTaDDGmvfg A-OQYRIKvJugdegm5JWM (Accessed on May 22, 2022) 44 WHO, “WHO Director-General commends United States decision to support temporary waiver on intellectual property rights for COVID-19 vaccines”, May 05, 2021, https://www.who.int/news/item/05-05-2021who-director-general-commends-united-states-decision-to-supporttemporary-waiver-on-intellectual-property-rights-for-covid-19-vaccines (Accessed on June 07, 2022) 45 WHO, “WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020”, March 11, 2020, https://www.who.int/director-general/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-media-briefing-on-covid-19 -11march-2020 (Accessed on May 28, 2022) 46 WHO, “WHO Director-General’s opening remarks at the 2021 SADC seminar on TRIPS waiver - 23 November 2021”, November 23, 2021 https://www.who.int/director-general/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-2021-sadc-seminar-on-trips-waiver 23-november-2021 (Accessed on June 07, 2022) 47 WHO, “WHO model list of essential medicines - 22nd list, 2021”, September 30, 2021, https://www.who.int/publications/i/item/WHOMHP-HPS-EML-2021.02 (Accessed on May 22, 2022) 87 48 Workers’ Group EESC, “TRIPS waiver: end the deadlock to the COVID vaccine patents”, December 09, 2021, https://www.eesc.europa.eu/en/news-media/news/trips-waiver-enddeadlock-covid-vaccine-patents-workers-group-statement (Accessed on June 07, 2022) 49 WTO, “Director-General Okonjo-Iweala hails breakthrough on TRIPS solution”, COVID-19 March 16, 2022, https://www.wto.org/english/news_e/news22_e/dgno_16mar22_e.htm (Accessed on June 06, 2022) 50 WTO, “Members discuss intellectual property response to the COVID-19 pandemic”, October 20, 2020, https://www.wto.org/english/news_e/news20_e/trip_20oct20_e.htm (Accessed on June 06, 2022) 51 WTO, “The WTO General Council”, https://www.wto.org/english/thewto_e/gcounc_e/gcounc_e.htm (Accessed on June 02, 2022) 52 WTO, “Trade and health: WTO response to the COVID-19 pandemic”, https://www.wto.org/english/thewto_e/minist_e/mc12_e/briefing_notes_ e/bftrade_and_health_e.htm (Accessed on June 16, 2022) 53 WTO, “Twelfth WTO Ministerial Conference”, https://www.wto.org/english/thewto_e/minist_e/mc12_e/mc12_e.htm (Accessed on June 07, 2022) 54 WTO, “Waivers – 2019 – Note by the Secretariat”, https://docs.wto.org/dol2fe/Pages/FE_Search/FE_S_S009DP.aspx?language=E&CatalogueIdList=259951&CurrentCatalogueIdInd ex=0&FullTextHash=371857150&HasEnglishRecord=True&HasFrench Record=True&HasSpanishRecord=True (Accessed on June 06, 2022) 88 55 WTO, “Trade and health: WTO response to the COVID-19 pandemic”, https://www.wto.org/english/thewto_e/minist_e/mc12_e/briefing_notes_ e/bftrade_and_health_e.htm (Accessed on June 18, 2022) 56 Yousuf Vawda, Fatima Hassan and Tian Johnson, “OPINION - New WTO deal is a slap in the face for poorer countries”, fin24, June 18, 2022, https://www.news24.com/fin24/opinion/opinion-new-wto-deal-isa-slap-in-the-face-for-poorer-countries-20220618 (Accessed on June 18, 2022) ... about the access vaccines from the perspective of HRs and the waiver of IP rights toward CVOID -19 vaccines, the author decided to choose the topic ? ?Enhance fair access to COVID- 19 vaccines through. .. of the study Studying the bachelor thesis named ? ?Enhance fair access to COVID- 19 vaccines through the waiver of Intellectual Property rights - Recommendations for Vietnam? ??, the author seeks to. .. assessing the actual situation, the author would observe on the issues surrounding the enhancement of fair access to COVID- 19 vaccines through the waiver of IP rights in the current context Purposes of